Document:

Resignation and Release Agreement

 Exhibit 10.1 
 RESIGNATION AND RELEASE AGREEMENT 
 This Resignation and Release Agreement
(this “Agreement”) is made between Daryl H. Mechem (“Executive”) and DCT Industrial Trust Inc. (the “Company”; together with Executive, the “Parties,” and each of which, a “Party”). 

WHEREAS, the Parties entered into an employment agreement dated October 9, 2009, (the “Employment Agreement”)
which, among other things, specifies a three-year term for the Employment Agreement (the “Term”); 
 WHEREAS,
Executive has expressed his desire to resign as of July 26, 2011; 
 WHEREAS, notwithstanding any terms to the
contrary contained in the Employment Agreement, the Company is nevertheless prepared to provide to Executive the benefits described in Section 3 of this Agreement (the “Termination Benefits”), subject to Executive’s execution and
non-revocation of the provisions of Section 5 of this Agreement; 
 NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, Executive and the Company hereby agree as follows: 
 1.
Resignation of Employment. Executive hereby resigns from his employment with the Company as its Managing Director, West Region, as of the close of business on July 26, 2011 (the “Resignation Date”). Executive confirms
that he is hereby resigning from any and all other positions that he holds with the Company as an officer, director or otherwise effective on the Resignation Date. Executive further confirms that he is hereby resigning from any and all positions
that he may hold with any affiliate of the Company effective on the Resignation Date. For purposes of the Employment Agreement, Executive hereby agrees that the termination of Executive’s employment on the Resignation Date pursuant to this
Agreement will be considered a termination of Executive’s employment by Executive without Good Reason (as defined in the Employment Agreement). 
 2. Non-Contingent Payments. No later than 30 days following the Resignation Date, and in all events no later than the date required by applicable law, the Company will pay the following to
Executive: (a) all of Executive’s annual salary accrued and unpaid through the Resignation Date; (b) all vested benefits accrued through the Resignation Date, if any, under the terms of any employee benefit plans applicable to
Executive; (c) reimbursement for any and all reasonable business expenses incurred by Executive prior to the Resignation Date pursuant to the terms of the Company’s expense reimbursement policy; and (d) Executive’s accrued but
unused vacation time. 
 3. Termination Benefits. Provided that Executive executes this Agreement and does not revoke the
provisions of Section 5 of this Agreement in accordance with the terms of Section 11 below, the Company shall provide the following benefits to Executive: 
 (a) Health Coverage Continuation. Provided that Executive elects to continue his health coverage to the extent authorized by and consistent with 29 U.S.C. § 1161 et seq. (commonly known
as “COBRA”), the Company will provide Executive with such continuing 

  
 1 

 
coverage under the Company’s group health plans as Executive would have received under his Employment Agreement (and at such costs to Executive) as would have applied in the absence of such
termination from the Resignation Date through the earlier of July 31, 2012 or such time as Executive becomes entitled to receive benefits of the same type from another employer or recipient of Executive’s services (such entitlement being
determined without regard to any individual waivers or other similar arrangements); and 
 (b) Lapse of Stock Vesting
Conditions and Restrictions. On the later of the Resignation Date or the Release Effective Date, the unvested stock options in the Company and LTIP Units in DCT Industrial Operating Partnership LP (the “Partnership”) granted to
Executive that are listed on Exhibit A attached hereto will become fully vested. All other equity awards (or portions thereof) made to Executive by the Company or the Partnership that were unvested immediately prior to the Resignation Date
will be forfeited as of the Resignation Date. 
 4. Tax Treatment. The Company shall undertake to make deductions, withholdings
and tax reports with respect to payments and benefits under this Agreement to the extent that it reasonably and in good faith determines that it is required to make such deductions, withholdings and tax reports. Payments under this Agreement shall
be in amounts net of any such deductions or withholdings. Nothing in this Agreement shall be construed to require the Company to make any payments to compensate Executive for any adverse tax effect associated with any payments or benefits or for any
deduction or withholding from any payment or benefit. 
 5. Mutual Release. 

(a) By Executive 

Executive irrevocably and unconditionally releases and forever discharges the Company, all of its affiliated and related entities, its and their
respective predecessors, successors and assigns, its and their respective employee benefit plans and the fiduciaries of such plans, and the current and former officers, directors, stockholders, employees, attorneys, accountants, and agents of each
of the foregoing in their official and personal capacities (collectively referred to as the “Company Releasees”) generally from all claims, demands, debts, damages and liabilities of every name and nature, known or unknown
(“Claims”) that, as of the date when Executive signs this Agreement, he has, ever had, now claims to have or ever claimed to have had against any or all of the Company Releasees. This release includes, without implication of limitation,
the complete release of all Claims of or for: breach of express or implied contract (including, but not limited to the Employment Agreement); wrongful termination of employment, whether in contract or tort; intentional, reckless, or negligent
infliction of emotional distress; breach of any express or implied covenant of employment, including the covenant of good faith and fair dealing; interference with contractual or advantageous relations, whether prospective or existing; deceit or
misrepresentation; discrimination or retaliation under state, federal, or municipal law, including, without implication of limitation, Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq., as amended, the
Americans with Disabilities Act, 42 U.S.C. § 12101 et seq., the Age Discrimination in Employment Act, 29 U.S.C. § 621 et seq., as amended by the Older Workers Benefit Protection Act (collectively referred to as the “ADEA”), and
Colorado Revised Statutes 23-34-402 (Discriminatory or Unfair Employment Practices); defamation or damage to reputation; reinstatement; punitive or emotional distress damages; wages, severance pay,

  
 2 

 
vacation pay, back or front pay or other forms of compensation; and attorney’s fees and costs. Executive understands that this general release of Claims extends to any and all claims related
to Executive’s employment by the Company and the termination of his employment; provided that nothing in this Section 5(a) shall be understood to constitute a release by Executive of his rights (a) to indemnification or
directors and officers liability insurance coverage, if any, as set forth in Section 3.7 of the Employment Agreement; (b) bring any Claims against any of the Company Releasees if any of the Company Releasees first asserts a Claim against
Executive; or (c) under this Agreement. 
 Executive understands that this general release does not extend to any rights or claims that may
arise out of acts or events that occur after the date on which Executive signs this Agreement, including, but not limited to, claims under the ADEA. Executive represents that he has not assigned to any third party and has not filed with any agency
or court any Claim released by this Agreement. 
 (b) By the Company 

The Company irrevocably and unconditionally releases and forever discharges Executive and his successors, heirs, assigns, executors, administrators and/or
estate (collectively referred to as the “Executive Releasees”) generally from all Claims that, as of the date when the Company signs this Agreement, the Company has, ever had, now claims to have or ever claimed to have had against any or
all of the Executive Releasees that directly or indirectly arise out of, relate to or concern acts or omissions reasonably taken or not taken in good faith by Executive in the course of his employment with the Company. The Company represents and
warrants it is not aware of any Claims that it has or may have against Executive as of the date when the Company signs this Agreement. 
 6. Restrictive Covenants. Executive hereby reaffirms his continuing obligations to be subject to the obligations set forth in Section 6 of the Employment Agreement, which are
incorporated herein by reference (collectively, the “Restrictive Covenants”). Notwithstanding the foregoing, provided that Executive executes this Agreement and does not revoke the provisions of Section 5 of this Agreement in accordance
with the terms of Section 11 below, Executive shall not be bound by the obligations set forth Section 6(a) of the Employment Agreement from and after the date that is 90 days after the Release Effective Date. 

7. Return of Property; Future Cooperation. Executive agrees that, within two business days following the Resignation Date, he will
return all Company property that is in his possession, custody or control, including, without limitation, computer equipment, computer passwords, software, cellular telephones, keys and access cards, credit cards, files and any other documents
(including computerized data and any copies made of any computerized data or software) containing information concerning the Company, its business or customer and client relationships (in the latter two cases, actual or prospective). Subsequent to
the return of such property, the Company will give Executive back the laptop computer and iPad that was provided to him by the Company during his employment after the Company has had an opportunity to copy and/or remove all Company-related
information from such devices, following which time such devices may be retained by Executive. In addition, Executive agrees to provide the Company with a list and status summary of all outstanding matters, projects, commitments, work

  
 3 

 
assignments and other related matters in which he was involved or working on behalf of the Company as of the Resignation Date and to provide his professional and reasonable assistance to the
Company in transitioning and completing such work, including, but not limited to, transitioning organizational, leasing and acquisition matters on which Executive had a role and, upon the Company’s request, assisting, as directed by the
Company, in consummating any such lease or acquisition matters. The Company shall not utilize this Section 7 to require Executive to make himself available to an extent that would unreasonably interfere with full-time employment
responsibilities that he may have. 
 8. Non-Disparagement. Executive will refrain from making any disparaging statements,
taking any actions, or conducting himself in any way that adversely affects the reputation or good will of the Company and/or its affiliated entities and the current and former officers, directors, shareholders, employees and agents of any of them.
The Company agrees that it will instruct those of its directors and officers who are aware of the existence and terms of this Agreement not to make any disparaging statements, take any actions or conduct themselves in any way that adversely affects
Executive’s reputation or goodwill. The non-disparagement obligations shall not in any way affect the obligation of the Executive or of the Company, or its directors, officers, employees or agents to testify truthfully in any legal proceeding.

 9. Non-Cooperation with Adverse Litigation. Executive agrees that he shall not voluntarily provide information to or otherwise
cooperate with any individual or entity that is contemplating or pursuing litigation against any of the Company Releasees or that is undertaking any investigation or review of any of the Company Releasees’ activities or practices;
provided, however, that Executive may participate in or otherwise assist in any investigation or inquiry conducted by the EEOC or the Colorado Department of Labor & Employment. Notwithstanding the foregoing, this provision shall not
apply to the extent that Executive’s breach of this Agreement consists of initiating a legal action in which he contends that the release set forth in Section 5 is invalid, in whole or in part, due to the provisions of 29 U.S.C.
§626(f). 
 10. Termination of Termination Benefits. Executive acknowledges that his right to the Termination Benefits and
his early release from the Restrictive Covenant set forth in Section 6(a) of the Employment Agreement as set forth in Section 6 of this Agreement is conditional on his compliance with the terms of this Agreement, including, without
limitation, Executive’s compliance with the Restrictive Covenants that continue in effect pursuant to Section 6 of this Agreement. In the event that Executive fails to comply with any of the terms of this Agreement, in addition to any
other legal or equitable remedies it may have for such breach, the Company shall have the right to terminate or recoup the Termination Benefits set forth in Section 3 of this Agreement. The termination or recoupment of those payments in the
event of such breach by Executive shall not affect the ongoing applicability of the terms of this Agreement. 
 11. Time for
Consideration; Release Effective Date. Executive acknowledges that he has been advised to consult with an attorney before signing this Agreement. Executive has the opportunity to consider this Agreement for twenty-one (21) days before
signing it. To accept this Agreement, he must return a signed original of this Agreement so that it is received by John G. Spiegleman, Executive Vice President, General Counsel and Secretary at or before the expiration of this twenty-one
(21) day period. If Executive signs this Agreement within less than twenty-one (21) days of the date of its delivery to him, Executive acknowledges by signing this 

  
 4 

 
Agreement that such decision was entirely voluntary and that he had the opportunity to consider this Agreement for the entire twenty-one (21) day period. Executive acknowledges and agrees
that any changes or modifications to this Agreement shall not restart or in any way affect the original twenty-one (21) day consideration period. For a period of seven (7) days from the day of his execution of this Agreement, Executive
shall retain the right to revoke the provisions of Section 5 of this Agreement by written notice that must be received by Mr. Spiegleman before the end of such revocation period. The provisions of Section 5 of this Agreement shall
become effective on the business day immediately following the expiration of the revocation period (the “Release Effective Date”), provided that Executive does not revoke such provisions during the revocation period. Executive acknowledges
that he has not been induced to sign this Agreement by any representations of the Company other than those set forth in this Agreement. In the event that Executive exercises his right to revoke the provisions of Section 5 of this Agreement, the
Parties acknowledge that all of the terms and conditions of this Agreement, other than those set forth in Section 5, shall remain in full force and effect; provided that those obligations that are contingent upon Executive not exercising such
right of revocation (e.g., his right to the Termination Benefits and his early release from the Restrictive Covenant set forth in Section 6(a) of the Employment Agreement) shall not arise. 

12. Enforceability. Executive acknowledges that, if any portion or provision of this Agreement or the Restrictive Covenants (including,
without limitation, any portion or provision of any section of those agreements) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder, other than those as to which it is so declared
illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 
 13. Entire Agreement. This Agreement along with the Restrictive Covenants constitute the entire agreement between Executive and the Company concerning Executive’s relationship with the
Company, and supersedes and replaces any and all prior agreements and understandings between the Parties concerning Executive’s relationship with the Company including, but not limited to the Employment Agreement. 

14. Enforcement. 

(a) The Company and Executive intend to and hereby confer jurisdiction to enforce the Restrictive Covenants incorporated in Section 6
upon the courts of any jurisdiction within the geographical scope of the Restrictive Covenants. 
 (b) Any controversy or claim
arising out of or relating to this Agreement or the breach of this Agreement (other than a controversy or claim arising under Section 6, to the extent necessary for the Company to avail itself of the rights and remedies referred to in
Section 6.2 of the Employment Agreement) that is not resolved by Executive and the Company shall be submitted to arbitration in Denver, Colorado in accordance with Colorado law and the procedures of the American Arbitration Association before a
single arbitrator. The determination of the arbitrator shall be conclusive and binding on the Company and Executive and judgment may be entered on the arbitrator’s award in any court having jurisdiction. The Company shall bear one-half of the
costs of any arbitration and Executive, as the other party to the arbitration, shall bear the other half; each party will bear its own attorney’s fees and costs. 

  
 5 

 15. Waiver. No waiver of any provision of this Agreement shall be effective unless made in
writing and signed by the waiving party. The failure of either Party to require the performance of any term or obligation of this Agreement, or the waiver by either Party of any breach of this Agreement, shall not prevent any subsequent enforcement
of such term or obligation or be deemed a waiver of any subsequent breach. 
 16. Governing Law; Interpretation. This Agreement
shall be interpreted and enforced under the laws of the State of Colorado, without regard to conflict of law principles. In the event of any dispute, this Agreement is intended by the parties to be construed as a whole, to be interpreted in
accordance with its fair meaning, and not to be construed strictly for or against either Party or the “drafter” of all or any portion of this Agreement. 
 17. Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original, but all of which together shall
constitute one and the same document. 
 IN WITNESS WHEREOF, the Parties, intending to be legally bound, have executed
this Agreement on the date(s) indicated below. 
 DCT Industrial Trust Inc. 

 

							
	By:	  	 /s/ John G. Spiegleman
	  		 	 July 26, 2011

		  	John G. Spiegleman	  		 	Date
		  	Executive Vice President and General	  		 	
		  	Counsel	  		 	

 I HAVE READ THIS AGREEMENT THOROUGHLY, UNDERSTAND ITS TERMS AND HAVE SIGNED IT KNOWINGLY AND VOLUNTARILY. I UNDERSTAND
THAT THIS AGREEMENT IS A LEGAL DOCUMENT.  
  

							
		  	 /s/ Daryl H. Mechem
	  		 	 July 26, 2011

		  	Daryl H. Mechem	  		 	Date
		  		  		 	
		  		  		 	

  
 6 

 Exhibit A 

Executive’s Accelerated Equity Awards 
 Subject to the terms of Section 3 of this Agreement, on the later of the Resignation Date or the Release Effective Date, the following portions of the stock option and LTIP Unit awards previously
granted to Executive that were unvested immediately prior to the Resignation Date will become fully vested: 
 Stock option for
7,853 shares of common stock of the Company granted on January 11, 2007 with an exercise price of $11.46 per share. 
 Stock
option for 27,344 shares of common stock of the Company granted on February 11, 2008 with an exercise price of $8.64 per share. 
 Stock option for 35,000 shares of common stock of the Company granted on February 10, 2009 with an exercise price of $3.41 per share. 

Stock option for 14,568 shares of common stock of the Company granted on February 11, 2010 with an exercise price of $4.56 per share.

 Stock option for 11,897 shares of common stock of the Company granted on February 3, 2011 with an exercise price of $5.55
per share. 
 3,141 LTIP Units in the Partnership granted on February 13, 2007. 

8,102 LTIP Units in the Partnership granted on February 22, 2008. 

41,056 LTIP Units in the Partnership granted on February 25, 2009. 

53,290 LTIP Units in the Partnership granted on February 25, 2010. 

30,710 LTIP Units in the Partnership granted on February 18, 2011. 

  
 A-1Wafer Supply Agreement

 Exhibit 10.1 
 Execution Copy 
 WAFER SUPPLY AGREEMENT AMENDMENT NO. 1 

This First Amendment to the WAFER SUPPLY AGREEMENT (this “Amendment”), dated as of March 29, 2011, amends that
certain Wafer Supply Agreement, dated March 2, 2009, (the “Agreement”) by and among (i) Advanced Micro Devices, Inc., a Delaware corporation (“AMD”); (ii) with respect to all of the provisions in the
Agreement other than those in Sections 5.5(a), 6.2 and 7.3(a) of the Agreement and the related provisions of the Agreement in connection with sales activities only (though without limiting FoundryCo’s guarantee obligations pursuant to
Section 15.7 of the Agreement), GLOBALFOUNDRIES Inc., an exempted company incorporated under the laws of the Cayman Islands (“FoundryCo”), on behalf of itself and its direct and indirect wholly-owned subsidiaries, including all
FoundryCo Sales Entities and FoundryCo Manufacturing Entities, as further set forth in the Agreement; (iii) subject to FoundryCo’s guarantee obligations pursuant to Section 15.7 of the Agreement, GLOBALFOUNDRIES U.S. Inc., a Delaware
corporation and a wholly owned subsidiary of FoundryCo (“USOpCo”), which is a party to the Agreement solely with respect to Sections 5.5(a), 6.2 and 7.3(a) of the Agreement and the related provisions of the Agreement in connection
with USOpCo’s sales activities; and (iv) subject to FoundryCo’s guarantee obligations pursuant to Section 15.7 of the Agreement, GLOBALFOUNDRIES Singapore Pte. Ltd., a private limited Singapore company and a wholly owned
subsidiary of FoundryCo (“GFS”), which, by executing this Amendment, is becoming a party to the Agreement solely with respect to Sections 5.5(a), 6.2 and 7.3(a) of the Agreement and the related provisions of the Agreement in
connection with GFS’ sales activities. 
 WHEREAS, the parties wish to modify certain pricing and other terms of the Wafer
Supply Agreement with respect to MPU Products to be delivered by FoundryCo to AMD during 2011 as well as regarding certain payments to be made by AMD in 2012 relating to MPU Products; and 

WHEREAS, the parties wish to permanently amend the Agreement with respect to GPU Products, Chipset Products (as defined below) and
FoundryCo Sales Entities; 
 NOW, THEREFORE, in consideration of the promises and the mutual agreements and covenants
hereinafter set forth, and intending to be legally bound, the parties hereby agree as follows: 
 1.    AMENDMENTS
RELATED TO GPU PRODUCTS 
 1.1    Section 1.52.1 

The following defined term shall be added to the Agreement immediately following Section 1.52 of the Agreement: 

  
 [****] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been
requested with respect to the omitted portions. 

 1.52.1 “GPU Plan of Record” shall mean a long-range planning
document prepared by AMD, as amended from time to time as provided in Section 2.1(c), that outlines AMD’s planned tape-out and production schedule for each GPU Product, and identifying each GPU Product Family. 

1.2    Section 1.53.1 
 The following defined term shall be added to the Agreement immediately following Section 1.53 of the Agreement: 
 1.53.1 “GPU Product Family” means any group of GPU Products that are developed by AMD as part of a single product marketing and design cycle and that are generally differentiated
by AMD from other GPU Products based on performance, power and cost, as identified by AMD in the GPU Plan of Record. 
 1.53.2
“GPU Product Technology Readiness Condition” means, with respect to each GPU Product, a condition that shall be deemed to be satisfied if and when FoundryCo has achieved, on or before the GPU Product Technology Readiness
Date, the passage of the certain [****] criteria which define a set of important parameters related to [****] milestones (the “Critical Parameters”). The definition of Critical Parameters for each GPU Product will be mutually agreed
in good faith by AMD and FoundryCo. In the event that AMD shall change the GPU Plan of Record, the parties agree to meet in good faith to determine whether such change requires any corresponding changes to the Critical Parameters. FoundryCo and AMD
will evaluate the achievement of the Critical Parameters in accordance with industry standard practice, and based on such evaluation will jointly and in good faith determine whether this condition is substantially or sufficiently satisfied for the
purposes of Section 2.1(c)(ii)(A), (B) and (C). 
 1.53.3 “GPU Product Technology Readiness
Date” means, with respect to each GPU Product, a date to be mutually agreed in good faith by AMD and FoundryCo as the earliest date at which the parties will determine whether the GPU Product Technology Readiness Condition has been
satisfied. Specifically, for the purposes of the GPU Volume Ramp Products, the GPU Product Technology Readiness Date shall be [****], provided that the parties will jointly evaluate by [****] whether or not FoundryCo will satisfy the GPU Product
Technology Readiness Condition for the [****] GPU Product Family by [****], and if necessary, will discuss and implement an action plan that enables AMD to award GPU Volume Ramp Products to FoundryCo. 

1.3    Section 2.1(c) 
 Section 2.1(c) of the Agreement shall be amended and restated in its entirety to read as follows: 
 (c)    GPU Products. 
 i.    AMD
and FoundryCo each commits to, and the parties agree to work together to, [****] manufacture GPU Products via a high volume bulk process at the [****]nm Process Node and at all future smaller Process Nodes, with Specifications to be agreed

  
 2 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 
upon in advance by the parties in writing. AMD’s obligations and commitments set forth below under this Section 2.1(c) are subject to the satisfaction by FoundryCo of the GPU Product
Technology Readiness Condition applicable to any given GPU Product, on or before the GPU Product Technology Readiness Date applicable to such GPU Product. FoundryCo acknowledges and agrees that all GPU Product commitments of AMD are subject to the
[****] process set forth in Exhibit B, which includes without limitation an analysis of FoundryCo’s ability to manufacture any such GPU Products at [****]. 
 ii.    In order to assist FoundryCo to establish FoundryCo’s ability to meet AMD’s demand for GPU Products, AMD commits (subject to the condition set forth in
Section 2.1(c)(i)) to have FoundryCo manufacture: [****] (collectively, these [****] GPU Products are the “GPU Volume Ramp Products”). AMD shall also (x) supply to FoundryCo or to [****], or (y) provide to FoundryCo a
version of [****] or [****] in a [****] architecture so that FoundryCo can [****], in each case as the parties mutually agree is suitable [****] to support FoundryCo’s manufacturing readiness for the [****] GPU Product Family. 

A.    In the event that FoundryCo has [****] achieved [****] of the Critical Parameters by the GPU Product
Technology Readiness Date for the GPU Volume Ramp Products, then AMD shall [****] the GPU Volume Ramp Products at FoundryCo and shall [****] of AMD’s requirements for the GPU Volume Ramp Products from FoundryCo. 

B.    In the event that FoundryCo has achieved [****] of the Critical Parameters by the GPU Product Technology
Readiness Date for the GPU Volume Ramp Products, [****] has met [****] Critical Parameters to be [****] to [****] the GPU Product Technology Readiness Condition and [****] the [****] for each GPU [****] Product, then FoundryCo and AMD shall identify
and mutually agree on [****] actions (the “[****] Actions”) to be [****] in the shortest period of time (such time period to be agreed upon in advance) for each GPU Product (the “[****] Time”). 

(a)    If FoundryCo completes [****] Actions within the [****] Time, then AMD shall [****] the GPU Volume Ramp
Products at FoundryCo and shall [****] of AMD’s requirements for the GPU Volume Ramp Products from FoundryCo. 

(b)    If FoundryCo completes [****] Actions after the [****] Time [****] before [****], then AMD shall use
commercially reasonable efforts to [****] GPU Volume Ramp Products at FoundryCo and to [****] of its requirements for the GPU Volume Ramp Products at FoundryCo. 
 C.    In the event that FoundryCo [****] achieve [****] a [****] number of Critical Parameters by the GPU Product Technology Readiness Date for the GPU Volume Ramp Products to be
[****] to [****] the [****] for any such Product, then FoundryCo shall not be [****] in accordance with the procedures set forth in Exhibit B in accordance with Section 2.1(c)(i), and AMD may [****] for the GPU Volume Ramp Products. 

  
 3 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 D.    In order to implement these commitments with respect to the GPU
Volume Ramp Products, the parties further agree as follows: 
 (a)    AMD may continue to work with other
foundry partners to design and prepare to manufacture GPU Products from the [****] GPU Product Family, as long as such design efforts do not divert design and engineering resources from the joint development effort described in the following
paragraph. 
 (b)    Immediately upon completion of the design activity for the [****] currently code-named
[****] which is currently scheduled to be completed [****], AMD and FoundryCo shall each commit [****] full-time-equivalent, highly qualified and experienced design engineers (including engineers currently committed to the [****] design efforts, or
other engineers mutually acceptable to the other party), together with their associated support resources, to a joint AMD/FoundryCo effort to complete, on or before [****], the full suite of Intellectual Property required for [****] and [****]
targeted to be manufactured at FoundryCo using FoundryCo’s [****]nm technology. 
 (c)    The
process-design interaction for the [****] GPU Product Family will be validated using [****]; provided that any additional Intellectual Property specific to the GPU Volume Ramp Products that is required to be silicon verified may be verified using
[****], with the cost to be [****]. 
 iii.    AMD agrees that, starting with the GPU Product Family
currently code-named [****] AMD will purchase at least [****] percent ([****]%) of its requirements for GPU Products measured on a [****] basis (such minimum percentage, the “GPU Minimum Percentage”) for the remaining duration of
this Agreement. In order to achieve the GPU Minimum Percentage, AMD commits (subject to the condition set forth in Section 2.1(c)(i)) to have FoundryCo manufacture at least [****] GPU Products from each of the [****] and [****] GPU Product
Families. 
 iv.    For the [****] and [****] GPU Product Families, FoundryCo and AMD shall determine
whether FoundryCo has [****],[****] or [****] the GPU Product Technology Readiness Condition for each GPU Product in the same manner set forth in Sections 2.1(c)(ii)(A), (B) and (C), with purchase commitments determined according to
Section 2.1(c)(iii). This determination shall be made on a Product-by-Product basis and shall not affect such determination for any other GPU Product or change the GPU Minimum Percentage. 

v.    If for an applicable quarter it is determined that AMD has not (A) placed orders for manufacture by
FoundryCo of the GPU Volume Ramp Products or the GPU Minimum Percentage of GPU Products starting with the [****] GPU Product Family, or (B) complied with any other requirements as set forth herein to enable FoundryCo the opportunity to
manufacture the GPU Minimum Percentage throughout the entire duration of this Agreement, the parties agree to meet, discuss and implement a mutually acceptable corrective action plan to address such non-compliance and to enable FoundryCo to
manufacture higher volumes of the GPU Products in the following quarters. 

  
 4 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 vi.    Cooperation and Partnership on GPU Products. In order
(A) to ensure the coordination of FoundryCo’s technology roadmap and development and implementation of necessary process technology in a timely manner to intersect AMD’s GPU Product roadmap on a schedule that will enable FoundryCo to
establish Qualified Processes for GPU Products and satisfy the GPU Product Technology Readiness Condition for each GPU Product by the GPU Product Technology Readiness Date for such GPU Product, as provided in this Section 2.1(c), (B) to
enable FoundryCo to meet AMD’s requirements to manufacture GPU Products so that AMD will purchase the GPU Volume Ramp Products as well as purchase the GPU Minimum Percentage as anticipated in subsection (iii) above, and (C) to allow
FoundryCo to compete for incremental GPU Products above the GPU Minimum Percentage, AMD and FoundryCo each commits to take the following steps with respect to GPU Products, with the intent of the parties to bring the same rigor and level of
collaboration to the GPU migration process that currently exists between AMD and FoundryCo in their partnership to develop and qualify processes for MPU Products: 
 A.    AMD shall share with FoundryCo on a timely basis AMD’s GPU Product roadmap schedules, detailed GPU Product requirements, detailed technology needs, forecasts of volume
requirements for all GPU Products by quarter, and all other pertinent information that AMD has that is related to AMD’s product requirements and technology needs for the applicable GPU Products, including information regarding device targets,
product performance requirements, and known process technology requirements (collectively, the “GPU Product Roadmap Information”). AMD agrees to deliver to FoundryCo the GPU Product Roadmap Information, together with all supporting
information reasonably requested by FoundryCo, as early as practicable to ensure that FoundryCo has time to develop and qualify the processes required for FoundryCo to manufacture GPU Products for AMD in accordance with such roadmaps and this
Section 2.1(c). AMD agrees to regularly update FoundryCo with additional GPU Product Roadmap Information consistent with the technology review and update process set forth in Schedule B to this Amendment. [****] In the event that, following the
[****] described in Exhibit B, AMD selects a foundry partner other than FoundryCo to manufacture a particular GPU Product, AMD shall [****] GPU Product Roadmap Information on such GPU Product [****] such time that AMD has taped out such GPU Product
at such other AMD foundry partner. In addition, AMD shall continuously [****] updated quarterly volume forecasts for each GPU Product [****] for as long as AMD is ordering such GPU Product from [****]. For the avoidance of doubt, AMD shall be
required to [****] the GPU Product Roadmap Information, beginning on the date hereof, for all GPU Products, regardless of whether or not FoundryCo has qualified a process to produce such products and regardless of whether AMD has committed or
intends to commit the production of all or some of its requirements for such GPU Products to one or more foundries other than FoundryCo. 
 B.    AMD shall establish an annual GPU Plan of Record that includes identified GPU Products with quarterly wafer volumes sufficient to first achieve and then maintain the GPU Minimum
Percentage as set forth above. FoundryCo acknowledges and agrees that AMD has sole discretion regarding the GPU Products it designs and decides to have manufactured, and as a result, subject to the obligations set forth in this Section 2.1,
including 

  
 5 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 
meeting the GPU Minimum Percentage as set forth above, AMD may change the GPU Plan of Record in response to changes in the GPU Product market or in AMD’s position in that market. 

C.    AMD and FoundryCo will establish separate GPU QTR/QBR and supporting meetings on a regular cadence (basis) to
track the parties’ product and process technology requirements and progress in order to achieve the GPU Product manufacturing and purchase commitments set forth in this Section 2.1(c) with the same rigor and level of collaboration as the
parties maintain in the development and manufacture of MPU Products. Specifically, AMD and FoundryCo shall initially use such processes to refine the GPU Plan of Record with the goal of establishing FoundryCo’s ability to manufacture GPU
Products and meeting the GPU Minimum Percentage as soon as practicable. 
 D.    The parties will develop
formalized executive level oversight of the commitments set out in this Section 2.1(c), including a designated executive at each of AMD and FoundryCo to drive and track progress towards achieving the GPU Product manufacturing targets set forth
in the GPU Plan of Record. In addition to the executive level oversight, each party shall document a process with senior management accountability to align mid-level management execution of the commitments set forth herein and coordinate
communications between such mid-level management at each party. This alignment process shall include participation by non-operational executives of FoundryCo and AMD. 
 vii.    For each GPU Product (including the first-tape out of such GPU Product), FoundryCo shall have a [****] in accordance with the process set forth in Exhibit B to manufacture such
GPU Product. For the avoidance of doubt, the parties agree that FoundryCo shall have such [****] in accordance with the process set forth in Exhibit B with respect to each GPU Product (whether or not such GPU Product is the first GPU Product) at
each [****] of [****]. 
 viii.    AMD agrees not to sell, transfer or otherwise dispose of all or
substantially all of its or its Subsidiaries’ assets related to GPU Products and related technology (including the equity interests of ATI Technologies ULC or its other subsidiaries that own such assets) to any person (other than to AMD or
another of its Subsidiaries) without the consent of FoundryCo, unless the transferee (A) agrees to be bound by the provisions of this Agreement with respect to GPU Products, including FoundryCo’s [****] with respect to each GPU Product and
the commitments to purchase the GPU Volume Ramp Products as set forth in this Section 2.1(c), and (B) agrees to purchase, on an annual basis, GPU Products in an amount at least equal to the GPU Minimum Percentage. 

  
 6 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 2.    AMENDMENTS RELATED TO CHIPSET PRODUCTS 

2.1    Section 1.29.1 
 The following defined term shall be added to the Agreement immediately following Section 1.29: 

1.29.1 “Chipset Products” shall mean one or more integrated circuits marketed and sold by AMD as a separate product, that
are manufactured at the [****]nm and any smaller Process Node, and that are designed to mediate the flow of data between the central processing unit and peripheral devices utilizing a PCI, PCIe, universal serial bus (USB), Serial ATA (SATA), low pin
count (LPC), Integrated Drive Electronics (IDE), Azalia HD Audio (AZ), Serial Peripheral Interface (SPI), Secure Digital Input Output (SDIO) or similar bus.
 2.2    Section 2.1(f) 
 Section 2.1 of the
Agreement shall be amended by the addition of the following language as a new sub-Section 2.1(f), which shall read in its entirety as follows: 
 (f)    Chipset Volumes 
 i.    Each
party commits to, and the parties agree to work together to, establish FoundryCo’s ability to manufacture Chipset Products via a [****]nm bulk silicon process at the [****]nm Process Node and at all future smaller Process Nodes for which AMD
may purchase Chipset Products, with Specifications to be agreed upon in advance by the parties in writing. 

ii.    AMD agrees that, beginning with the [****] family of Chipset Products (or, subject to the last clause of this
paragraph (ii), any successor or replacement family of Chipset Products at the [****]nm and any smaller Process
Node)1, and continuing for the entire duration of this
Agreement, AMD will purchase [****]% of its requirements (including the requirements of its Subsidiaries) for any new Chipset Products from FoundryCo; provided, however, that if AMD purchases a company or assets from a company that has at the time
of acquisition, Chipset Products in production or that have already taped out for manufacture at a third party foundry, such acquired Chipset Products will not be subject to this Section 2.1(f). 

2.3    Section 7.1(c-2) 
 Section 7.1 of the Agreement shall be amended by the addition of the following language as a new sub-Section 7.1(c-2) (to be inserted between existing sub-Sections 7.1(c) and 7.1(d)), which
shall read in its entirety as follows: 
  
  

1
 As of the effective date of this Amendment, the [****] Chipset Product on AMD’s [****] is the one code-named [****]. 

  
 7 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 (c-2)    Chipset Product Pricing. The pricing for Chipset
Products shall be based on competitive market pricing. The price for Engineering Wafers for Chipset Products shall be determined by mutual written agreement of the parties on a case-by-case basis. 

3.    AMENDMENTS RELATED TO MPU PRODUCT PRICING IN 2011 

3.1    MPU Product Prices for 2011. 
 (a)    Notwithstanding Section 7.1 and Exhibit A of the Agreement, the price for MPU Products delivered by FoundryCo to AMD in 2011 (including MPU Products in both [****] and
[****] (as defined in Schedule D to this Amendment), and [****] containing MPU Products (“PQUL Wafers”)) shall be as set forth in Schedule D to this Amendment. 

(b)    Payment by AMD of the purchase price set forth in Schedule D to this Amendment for MPU Products delivered in
2011 shall be, with respect to such MPU Products, in lieu of the payment of (A) the price for [****] containing [****] set forth in Section 1 of Exhibit A to this Agreement, and (B) the price for [****] MPU Products set forth in
Section 4 of Exhibit A to the Agreement. Payments of the purchase prices set forth in Schedule D for MPU Products delivered in 2011, however, shall be exclusive of and shall not affect the obligation of AMD to pay for [****]. 

3.2    2011 Additional [****] Fixed Payments. In addition to the prices set forth for purchases by AMD of MPU
Products slated for delivery in 2011, AMD agrees to pay FoundryCo certain additional fixed [****] payments (the “2011 Additional [****] Fixed Payments”) as set forth in Schedule D. 

3.3    Consequence of Failure to be in Commercial Production in 2011 

(a)    FoundryCo shall be deemed to be in “Commercial Production in 2011” of [****] MPU Products if
either one of these events has occurred: (i) the achievement of the [****] milestone for the [****] (as defined in Schedule A to this Amendment); or (ii) AMD has ordered [****] MPU Product Production Wafers for delivery in [****] of 2011.

 (b)    In the event that FoundryCo does not enter into Commercial Production in 2011, then in lieu of
AMD’s obligation to pay for [****] MPU Products as set forth in Schedule D, FoundryCo may instead invoice any time after the [****] day of [****] of 2011, and before the [****] day of the [****], AMD will pay within forty-five (45) days of
the invoice date, [****] Dollars ($[****]]), representing [****] percent ([****]%) of FoundryCo’s [****] MPU Product fixed costs. FoundryCo acknowledges that if it does not achieve Commercial Production in 2011, then it will not have met the
conditions to be entitled to receive the 2012 Additional Quarterly Fixed Payments (as defined below), and as a consequence the 2012 Additional Quarterly Fixed Payments will not have been earned and will not be payable. 

  
 8 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 3.4    2012 Additional Quarterly Fixed Payments. 

(a)    Subject to the conditions set forth below, AMD will pay to FoundryCo the aggregate additional amount of Four
Hundred and Thirty Million Dollars ($430,000,000), payable in equal quarterly installments of One Hundred and Seven Million, Five Hundred Thousand Dollars ($107,500,000) (collectively, the “2012 Additional Quarterly Fixed
Payments”). The obligation to pay the 2012 Additional Quarterly Fixed Payments is contingent upon FoundryCo being in Commercial Production of [****] MPU Products in 2012, even if the Yields for such [****] MPU Products fall below the Target
Yield Curve (as defined in Schedule D) for such [****] MPU Products in 2012. 
 (b)    FoundryCo shall be
deemed to be in “Commercial Production of [****] MPU Products in 2012” if FoundryCo has achieved Commercial Production in 2011 (as defined above), and on or after [****] fiscal 2012 FoundryCo continues to offer committed
capacity to AMD to manufacture [****] MPU Product Production Wafers for delivery in 2012. 

(c)    Notwithstanding subsection 3.4(a) above, the 2012 Additional Quarterly Fixed payments are subject to
reduction in the event that FoundryCo earns any Yield Bonus Revenue as set forth in Section 12 of Schedule D. 

(d)    Subject to the provisions of this Amendment, [****] days prior to the end of [****] in 2012, FoundryCo shall
invoice, and AMD shall pay on or prior to the last day of [****], the applicable 2012 Additional Quarterly Fixed Payment. 

3.5    Reversion to Existing Pricing Model for MPU Products in 2012. On and after January 1, 2012, except
as set forth in Section 3.3 above, the parties will revert to the MPU Product pricing set forth in Section 7.1(a) and Exhibit A of the Agreement for all MPU Products. 

3.6    Other Payment Obligations in 2011. During 2011, except as explicitly set forth in this Amendment, the
parties will continue to perform their respective obligations under this Agreement, including forecasts, process implementation procedures, etc. The financial terms in Schedule D incorporate the payment of [****] Costs and [****] Costs under this
Agreement, but will not modify any other [****] or [****] obligations of the parties under the Agreement. With respect to [****] Wafer Outs containing [****]nm MPU Products that were originally ordered by AMD for delivery in [****], [****], such
[****] have been or will be invoiced at prices calculated according to Section 7.1(a) and Exhibit A of the Agreement, and the prices for [****] will not be modified by Schedule D of this Amendment. 

4.    AMENDMENTS RELATED TO FOUNDRYCO SALES ENTITIES 

4.1    Section 1.48 
 Section 1.48 of the Agreement shall be amended and restated in its entirety to read as follows: 

  
 9 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 1.48    “FoundryCo Sales Entities” shall mean
USOpCo, GFS, and any other direct or indirect wholly-owned subsidiaries of FoundryCo to which FoundryCo has delegated the responsibility to process purchase orders from AMD and to offer to sell and sell Products to AMD in accordance with this
Agreement. 
 5.    AMENDMENTS RELATED TO AUDIT PROVISIONS 

5.1    Additional Financial Review Procedures. Because this Amendment has established MPU Product prices for
2011 on a [****] basis, rather than on a [****] basis, the operational monitoring of the Agreement in 2011 will focus on a process that includes monthly reporting of product shipments, payments, Yield performance, [****], and a [****] (of billing
versus [****]). FoundryCo also agrees to support AMD’s monthly S&OP process, annual business planning process and the long range planning process. 
 5.2    Additional FoundryCo Audit Rights. During 2011, FoundryCo shall have audit rights, consistent with Section 8.1(b) of the Agreement, to verify AMD’s compliance
with its obligations with respect to [****] and [****] inventories and dispositions thereof. 

6.    AMENDMENT RELATED TO ALLOCATION OF ADDITIONAL [****] EXPENSES IN 2011 

6.1    Incremental FoundryCo [****] in 2011 for Implementing [****] Technology for AMD. During 2011 only, AMD
may periodically identify and request that FoundryCo invest in additional [****] for the purpose of enhancing product performance or supporting very specific product features for the [****] MPU Products. In the case where this [****] is unique,
unrelated to the established [****], and incremental to the FoundryCo base investment already disclosed to AMD as of the Effective Date of this Amendment, AMD acknowledges financial responsibility for the 2011 [****] associated with any such [****]
requested and approved by AMD. AMD requests for such [****] will be made during the monthly meetings between the parties’ [****], and the financial responsibility will be captured in the [****] process in 2011. As part of such [****], the
parties will agree in advance on the applicable [****] costs to be passed through to AMD prior to FoundryCo’s purchase of such [****]. After 2011, and for any [****] already incorporated into FoundryCo’s budget for 2011 and requested as an
incremental addition by AMD in 2011 as described above, the terms of the Agreement, rather than the terms of this Section 6 of the Amendment, shall apply. 
 7.    AMENDMENTS RELATED TO DISPUTE RESOLUTION 

7.1    Section 15.11 Governing Law; Dispute Resolution 

Section 15.11(c) of the Agreement shall be amended and restated in its entirety to read as follows: 

(c)    Any Dispute not resolved within thirty (30) days of the Dispute Notice being received shall be referred
to, and shall be finally and exclusively resolved by, arbitration under the LCIA Rules then in effect, as amended by this Section 15.11, which LCIA Rules are 

  
 10 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 
deemed to be incorporated by reference into this Section 15.11. The seat, or legal place, of the arbitration shall be London, England. The language of the arbitration shall be English. The
number of arbitrators shall be three. Each party shall nominate one arbitrator and the two arbitrators nominated by the parties shall, within thirty (30) days of the appointment of the second arbitrator, agree upon and nominate a third
arbitrator who shall act as Chairman of the Tribunal. If no agreement is reached within thirty (30) days, the LCIA Court shall appoint a third arbitrator to act as Chairman of the Tribunal. It is hereby expressly agreed that if there is more
than one claimant party or more than one respondent party, the claimant parties shall together nominate one arbitrator and the respondent parties shall together nominate one arbitrator. In the event that a sole claimant or the claimant parties, on
the one side, or a sole respondent or the respondent parties, on the other side, fails to nominate its/their arbitrator, such arbitrator shall be appointed by the LCIA Court. Any award issued by the arbitrators shall be final and binding upon the
parties, and, subject to this Section 15.11, may be entered and enforced in any court of competent jurisdiction by any of the parties. In the event any party subject to such final and binding award desires to have it confirmed by a final order
of a court, the only court which may do so shall be a court of competent jurisdiction located in London, England; provided however, that nothing in this sentence shall prejudice or prevent a party from enforcing the arbitrators’ final and
binding award in any court of competent jurisdiction. The parties hereto acknowledge and agree that any breach of the terms of this Agreement could give rise to irreparable harm for which money damages would not be an adequate remedy. Accordingly,
the parties agree that, prior to the formation of the Tribunal, the parties have the right to apply exclusively to any court of competent jurisdiction or other judicial authority located in London, England for interim or conservatory measures,
including, without limitation, to compel arbitration (an “Interim Relief Proceeding”). Furthermore, the parties agree that, after the formation of the Tribunal, the arbitrators shall have the sole and exclusive power to grant
temporary, preliminary and permanent relief, including injunctive relief and specific performance, and any then pending Interim Relief Proceeding shall be discontinued without prejudice to the rights of any of the parties thereto. Unless otherwise
ordered by the arbitrators pursuant to the terms hereof, the arbitrators’ expenses shall be shared equally by the parties. In furtherance of the foregoing, each of the parties hereto irrevocably submits to: (i) the exclusive jurisdiction
of the courts of England located in London, England in relation to any Interim Relief Proceeding and; (ii) the non-exclusive jurisdiction of the courts of England located in London, England with respect to the enforcement of any arbitral award
rendered in accordance with this Section 15.11; and, with respect to any such suit, action or proceeding, waives any objection that it may have to the courts of England located in London, England on the grounds of inconvenient forum. For the
avoidance of doubt, where an arbitral tribunal is appointed under this Agreement, the whole of its award shall be deemed for the purposes of the New York Convention on the Recognition and Enforcement of Foreign Arbitral Awards of 1958 to be
contemplated by this Agreement, as the case may be (and judgment on any such award may be entered in accordance with the provisions set forth in this Section 15.11). 
 8.     MISCELLANEOUS 

  
 11 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 Other than as expressly provided in this Amendment, no other amendments are being made to
the Agreement, and all other provisions of the Agreement shall remain in full force and effect in accordance with the terms of the Agreement. 

  
 12 

[****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 IN WITNESS WHEREOF, the parties have caused this Amendment to the Wafer Supply Agreement to
be executed as of the date first written above by their respective officers thereunto duly authorized. 
 [Signature pages
follow] 

  
 [****] = Certain
confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential
treatment has been requested with respect to the omitted portions. 

 
			
	ADVANCED MICRO DEVICES, INC.
	
	By: /s/ Thomas J.
Seifert                                        

	Name:	 	Thomas J. Seifert
	Title:	 	 Senior Vice President, Chief Financial
 Officer and Interim Chief Executive Officer

  
 Signature Page
to Amendment to the Wafer Supply Agreement 
 [****] = Certain confidential information contained in this document, marked by brackets, has been
omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 
			
	GLOBALFOUNDRIES INC.
		
	By:	 	 /s/ Chia Song Hwee

	 Name: Chia Song Hwee

Title: Chief Operating Officer

  
 Signature Page
to Amendment to the Wafer Supply Agreement 
 [****] = Certain confidential information contained in this document, marked by brackets, has been
omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 
			
	GLOBALFOUNDRIES U.S. INC.
		
	By:	 	 /s/ Robert Krakauer

	 Name: Robert Krakauer
 Title: CFO

  
 Signature Page
to Amendment to the Wafer Supply Agreement 
 [****] = Certain confidential information contained in this document, marked by brackets, has been
omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 
			
	GLOBALFOUNDRIES SINGAPORE PTE. LTD.
	
	By: /s/ Robert
Krakauer                                        

	Name: Robert Krakauer
	Title: CFO

  
 Signature Page
to Amendment to the Wafer Supply Agreement 
 [****] = Certain confidential information contained in this document, marked by brackets, has been
omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}]]